跨性别男性的卵巢组织卵母细胞特征显示钙释放和胚胎发育不良,纺锤体移植可能克服该问题
研究收集18名接受睾酮治疗的跨性别男性的卵巢组织,行体外成熟(OTO-IVM),评估卵母细胞钙释放、胚胎发育及纺锤体移植(ST)的效果。OTO-IVM卵母细胞钙释放能力和囊胚形成率显著低于对照,ST可提高第5天囊胚率至20.6%,与对照ICSI组25.4%相似。
要点
- 跨性别男性OTO-IVM卵母细胞钙释放能力(1.47 AU冷/1.03 AU温)显著低于对照(2.30 AU)。
- OTO-IVM卵母细胞第5天囊胚率0%(冷)和4.1%(温)显著低于对照25.4%。
- 纺锤体移植使OTO-IVM卵母细胞囊胚率从0%升至20.6%,与对照ICSI组25.4%相似。
核心结论
- 跨性别男性OTO-IVM卵母细胞质量较差,可能与其用于生育力保存的价值存疑。
- 纺锤体移植显示出一定潜力,可克服跨性别男性OTO-IVM卵母细胞的胚胎发育阻滞。
研究设计与样本
- 研究收集2020年11月至2022年9月期间18名接受卵巢切除术的跨性别男性的双侧卵巢,患者均在接受睾酮治疗,部分同时接受月经抑制治疗。
- 卵巢组织分别在冷或温培养基中收集,分离卵丘-卵母细胞复合体(COCs)并体外成熟48小时。
- 对照卵母细胞来自接受卵巢刺激的不孕症治疗女性,包括体外成熟的MI、GV卵母细胞和体内成熟的伴有滑面内质网聚集(SERa)的卵母细胞。
- 对OTO-IVM卵母细胞应用纺锤体移植(ST),以去核的成熟对照卵母细胞作为胞质受体。
- 胚胎进行评分并通过浅全基因组测序分析拷贝数变异(CNVs)。
主要发现
- 冷条件收集331个COCs(OTO-Cold),温条件收集282个COCs(OTO-Warm),成熟率分别接近54%和57%。
- 对照卵母细胞钙释放能力为2.30 AU(n=39),显著高于OTO-Cold的1.47 AU(n=33,P=0.046)和OTO-Warm的1.03 AU(n=31,P=0.036);两种收集温度的钙释放值相似。
- 线粒体膜电位在对照、OTO-Warm和OTO-Cold卵母细胞间无主要差异(P=0.417)。
- ICSI后,对照卵母细胞受精率为59/70(84.2%),显著高于OTO-Cold的19/47(40.4%)(P<0.01)和OTO-Warm的24/48(50%)(P<0.01)。
- 第5天囊胚形成率:对照组15/59(25.4%),显著高于OTO-Cold的0/19(0%)(P=0.014)和OTO-Warm的1/24(4.1%)(P=0.026)。
临床怎么用
- 作者认为,跨性别患者来源的OTO-IVM卵母细胞质量较差,对其用于生育力保存提出疑问。
- 作者指出,质量差可能与胞质因素有关,纺锤体移植后囊胚数增加支持这一观点。
- 作者建议,未来跨性别男性OTO-IVM研究应关注卵母细胞胞质内容或补充促进胞质成熟的培养基因子。
- 作者指出,目前缺乏关于睾酮治疗时长影响的更详细研究,无法为跨性别男性的生育选择提供更具体的指南和指导。
- 作者认为,实验性纺锤体移植在克服与胞质质量相关的胚胎发育不良方面可能具有有益作用。
局限性
- 由于人卵母细胞和卵巢组织获取有限,仅能研究有限数量的人卵母细胞和胚胎,结果应谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can spindle transfer (ST) overcome inferior embryonic development of in vitro matured ovarian tissue oocytes (OTO-IVM) originating from testosterone-treated transgender men? SUMMARY ANSWER: ST shows some potential to overcome the embryo developmental arrest observed in OTO-IVM oocytes from transgender men. WHAT IS KNOWN ALREADY: OTO-IVM is being applied as a complementary approach to increase the number of oocytes/embryos available for fertility preservation during ovarian tissue cryopreservation in cancer patients. OTO-IVM has also been proposed for transgender men, although the potential of their oocytes remains poorly investigated. Currently, only one study has examined the ability of OTO-IVM oocytes originating from transgender men to support embryo development, and that study has shown that they exhibit poor potential. STUDY DESIGN, SIZE, DURATION: Both ovaries from 18 transgender men undergoing oophorectomy were collected for the purposes of this study, from November 2020 to September 2022. The patients did not wish to cryopreserve their tissue for fertility preservation and donated their ovaries for research. All patients were having testosterone treatment at the time of oophorectomy and some of them were also having menses inhibition treatment. PARTICIPANTS/MATERIALS, SETTING, METHODS: Sibling ovaries were collected in either cold or warm medium, to identify the most optimal collection temperature. Cumulus oocyte complexes (COCs) from each condition were isolated from the ovarian tissue and matured in vitro for 48 h. The quality of OTO-IVM oocytes was assessed by calcium pattern releasing ability, embryo developmental competence following ICSI, and staining for mitochondrial membrane potential. In vitro matured metaphase I (MI) oocytes, germinal vesicle (GV) oocytes, and in vivo matured oocytes with aggregates of smooth endoplasmic reticulum (SERa) were donated from ovarian stimulated women undergoing infertility treatment and these served as Control oocytes for the study groups. ST was applied to overcome poor oocyte quality. Specifically, enucleated mature Control oocytes served as cytoplasmic recipients of the OTO-IVM spindles from the transgender men. Embryos derived from the different groups were scored and analysed by shallow whole genome sequencing for copy number variations (CNVs). MAIN RESULTS AND THE ROLE OF CHANCE: In total, 331 COCs were collected in the cold condition (OTO-Cold) and 282 were collected in the warm condition (OTO-Warm) from transgender men. The maturation rate was close to 54% for OTO-Cold and 57% for OTO-Warm oocytes. Control oocytes showed a calcium releasing ability of 2.30 AU (n = 39), significantly higher than OTO-Cold (1.47 AU, P = 0.046) oocytes (n = 33) and OTO-Warm (1.03 AU, P = 0.036) oocytes (n = 31); both values of calcium release were similar between the two collection temperatures. Mitochondrial membrane potential did not reveal major differences between Control, OTO-Warm, and OTO-Cold oocytes (P = 0.417). Following ICSI, 59/70 (84.2%) of Control oocytes were fertilized, which was significantly higher compared to 19/47 (40.4%) of OTO-Cold (P < 0.01) and 24/48 (50%) of OTO-Warm oocytes (P < 0.01). In total, 15/59 (25.4%) blastocysts were formed on Day 5 in the Control group, significantly higher than 0/19 (0%) from the OTO-Cold (P = 0.014) and 1/24 (4.1%) in OTO-Warm oocytes (P = 0.026). Application of ST rescued the poor embryo development, by increasing the Day 5 blastocyst rate from 0% (0/19) to 20.6% (6/29) (P = 0.034), similar to that in the ICSI-Control group (25.4%, 15/59). A normal genetic profile was observed in 72.7% (8/11) of OTO-Cold, 72.7% (8/11) of OTO-Warm and 64.7% (11/17) of Control Day 3-Day 5 embryos. After ST was applied for OTO-IVM oocytes, 41.1% (7/17) of the embryos displayed normal genetic patterns, compared to 57.1% (4/7) among ST-Control Day 3-Day 5 embryos. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Due to the limited access to human oocytes and ovarian tissue, our results should be interpreted with some caution, as only a limited number of human oocytes and embryos could be investigated. WIDER IMPLICATIONS OF THE FINDINGS: The results of this study, clearly indicate that OTO-IVM oocytes originating from transgender patients are of inferior quality, which questions their use for fertility preservation. The poor quality is likely to be related to cytoplasmic factors, supported by the increased blastocyst numbers following application of ST. Future research on OTO-IVM from transgender men should focus on the cytoplasmic content of oocytes or supplementation of media with factors that promote cytoplasmic maturation. A more detailed study on the effect of the length of testosterone treatment is also currently missing for more concrete guidelines and guidance on the fertility options of transgender men. Furthermore, our study suggests a potentially beneficial role of experimental ST in overcoming poor embryo development related to cytoplasmic quality. STUDY FUNDING/COMPETING INTEREST(S): A.C. is a holder of FWO grants (1S80220N and 1S80222N). A.B. is a holder of an FWO grant (1298722N). B.H. and A.V.S. have been awarded with a special BOF (Bijzonder Onderzoeksfonds), GOA (Geconcerteerde onderzoeksacties) and 2018000504 (GOA030-18 BOF) funding. B.H. has additional grants from FWO-Vlaanderen (Flemish Fund for Scientific Research, G051516N and G1507816N) and Ghent University Special Research Fund (Bijzonder Onderzoeksfonds, BOF funding (BOF/STA/202109/005)), and has been receiving unrestricted educational funding from Ferring Pharmaceuticals (Aalst, Belgium). The authors declare that they have no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Christodoulaki A, He H, Zhou M, et al. Characterization of ovarian tissue oocytes from transgender men reveals poor calcium release and embryo development, which might be overcome by spindle transfer. Hum Reprod. 2023. PMID: 37029914. doi:10.1093/humrep/dead068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。